SCHEMBL28339583

SCHEMBL28339583

Cc1nc(C2=CN=C(NC(C)C)N(C)C2=C=O)ccc1C(C)c1cn(C(=O)O)c2ncc(Cl)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21906297 0.76 CSF1R (0.43) —
SCHEMBL21906344 0.76 CSF1R (0.45) —
SCHEMBL21906323 0.74 IDH1 (0.33) —
SCHEMBL21873038 0.68 CSF1R (0.43) —
SCHEMBL21873001 0.67 CSF1R (0.44) —
SCHEMBL21872990 0.66 AAK1 (0.32) —
SCHEMBL21873122 0.59 CSF1R (0.44) —
SCHEMBL21873024 0.58 CSF1R (0.44) —
SCHEMBL28338103 0.55 CYP2C9 (0.31) —
SCHEMBL30491288 0.55 ELANE (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110461841-B Nitrogen heteroaryl derivative with CSF1R inhibitory activity, and preparation method and application thereof 上海和誉生物医药科技有限公司 2020-09-15 — — CN disclosed
CN-110461841-A A kind of azepine aryl derivatives, preparation method and application with CSF1R inhibitory activity ABBISKO THERAPEUTICS CO LTD 2019-11-15 — — CN disclosed
Send feedback